App-Quantinova.ai

Measuring what matters to lupus patients: translating patient views into novel patient-reported outcomes

S. Cleanthous - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Epratuzumab

Membranous versus proliferative lupus nephritis: two different diseases?

F. Farinha - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

N/A

Microarrays gene expression profiling of monocytes from systemic lupus erythematosus patients: novel genes and pathways involved in the disease

C. Perez-Sanchez - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Missing the big picture? an audit of hand x-rays in biologic treated rheumatoid arthritis patients

U. Habib - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Mitochondrial dna mutations and respiratory chain dysfunction in lung fibrosis of systemic sclerosis

V.K. Jaeger - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Monocyte downregulation of mitochondrial translocator protein may be a contributory mechanism to inflammation in ra

N. Narayan - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Glucocorticoid

Mri interosseous tendon inflammation occurs in anti-ccp positive at-risk individuals and may precede the development of synovitis

K. Mankia - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Orphenadrine Citrate

Mri lesion definitions in axial spondyloarthritis: a consensus reappraisal from the assessments in spondyloarthritis international society (ASAS

W.P. Maksymowych - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Multidisciplinary collaboration among young specialists: results of an ongoing international survey by young organisations

M. Kostine - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Posterior Reversible Encephalopathy Syndrome

N/A

Muscle elastography as a potential novel imaging biomarker in myositis

A.M. Alfuraih - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Juvenile dermatomyositis

N/A

Muscle ultrasonography: a potential new diagnostic tool for inflammatory myopathies

K. Bhansing - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Musculoskeletal problems amongst train operators: a collaborative approach to identify solutions

J. Erwin - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

New approaches in measuring what matters to patients – decision aid tools

H. Bekker - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

N/A

New insights into antibody-based therapies and disease susceptibilities revealed by microscopy of human nk cells

D.M. Davis - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non-Hodgkin's Lymphoma

Rituximab

New systemic sclerosis risk loci identified through a meta-gwas strategy

E. López-Isac - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Nice guidance on spondyloarthritis: recommendations supporting recognition and referral by physiotherapists & podiatrists

C. McCrum - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

N/A

No difference in effectiveness with either etanercept originator or biosimilar as first line biologic treatment for rheumatoid arthritis

D. De Cock - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Etanercept

Off-label secukinumab dose escalation in the treatment of moderate-to-severe psoriasis: a multicenter, retrospective study

M. Phung - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

secukinumab

Online social media platforms and public health information: an exploration into arthritis related videos on youtube in 2017

E. Heron - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Opioid prescribing: what’s the problem?

B.H. Smith - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Constipation

Epimorph

Filters

45280 Abstracts